{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:15:38Z","timestamp":1785802538996,"version":"3.56.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.SUMS.MED.REC. 1400.629"],"award-info":[{"award-number":["IR.SUMS.MED.REC. 1400.629"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["VirusDis."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13337-025-00926-w","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:11:28Z","timestamp":1755018688000},"page":"326-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MiR-155 and MiR-1275 relation with graft-versus-host disease and hepatitis B in hematopoietic stem cell transplant recipients"],"prefix":"10.1007","volume":"36","author":[{"given":"Mani","family":"Ramzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossain Ali","family":"Rostamipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-4684","authenticated-orcid":false,"given":"Mahdiyar","family":"Iravani Saadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhroddin","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahed","family":"karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shahhossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ahmadyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"926_CR1","doi-asserted-by":"publisher","first-page":"S330","DOI":"10.1016\/j.clml.2013.05.021","volume":"13","author":"I Danylesko","year":"2013","unstructured":"Danylesko I, Shimoni A, Nagler A. Allogeneic stem cell transplantation and targeted immunotherapy for multiple myeloma. Clin Lymphoma Myeloma Leukemia. 2013;13:S330\u201348.","journal-title":"Clin Lymphoma Myeloma Leukemia"},{"key":"926_CR2","doi-asserted-by":"publisher","first-page":"9451950","DOI":"10.1155\/2018\/9451950","volume":"2018","author":"A Kuba","year":"2018","unstructured":"Kuba A, Raida L. Graft versus host disease: from basic pathogenic principles to DNA damage response and cellular senescence. Mediators Inflammation. 2018;2018:9451950.","journal-title":"Mediators Inflammation"},{"issue":"2","key":"926_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3904\/kjim.2018.036","volume":"33","author":"SY Cho","year":"2018","unstructured":"Cho SY, Lee HJ, Lee DG. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. Korean J Intern Med. 2018;33(2):256\u201376.","journal-title":"Korean J Intern Med"},{"key":"926_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fimmu.2013.00420","volume":"4","author":"S Atarod","year":"2013","unstructured":"Atarod S, Dickinson AM. MicroRNAs: the missing link in the biology of graft-versus-host disease? Front Immunol. 2013;4:420.","journal-title":"Front Immunol"},{"issue":"6","key":"926_CR5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.molcel.2014.02.013","volume":"53","author":"J-W Nam","year":"2014","unstructured":"Nam J-W, Rissland OS, Koppstein D, Abreu-Goodger C, Jan CH, Agarwal V, et al. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol cell. 2014;53(6):1031\u201343.","journal-title":"Mol cell"},{"issue":"2","key":"926_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"key":"926_CR7","first-page":"287","volume":"9","author":"G Di Leva","year":"2014","unstructured":"Di Leva G, Garofalo M. Croce CMJARoPMoD. MicroRNAs Cancer. 2014;9:287\u2013314.","journal-title":"MicroRNAs Cancer"},{"issue":"6","key":"926_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/jir.2018.0155","volume":"39","author":"G Mahesh","year":"2019","unstructured":"Mahesh G, Biswas R. MicroRNA-155: a master regulator of inflammation. J Interferon Cytokine Res. 2019;39(6):321\u201330.","journal-title":"J Interferon Cytokine Res"},{"issue":"7","key":"926_CR9","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1074\/jbc.M113.522730","volume":"289","author":"SR Quinn","year":"2014","unstructured":"Quinn SR, Mangan NE, Caffrey BE, Gantier MP, Williams BR, Hertzog PJ, et al. The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10. J Biol Chem. 2014;289(7):4316\u201325.","journal-title":"J Biol Chem"},{"issue":"5824","key":"926_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.1141229","volume":"316","author":"T-H Thai","year":"2007","unstructured":"Thai T-H, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316(5824):604\u20138.","journal-title":"Science"},{"key":"926_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canlet.2017.04.007","volume":"407","author":"TC Ivkovic","year":"2017","unstructured":"Ivkovic TC, Voss G, Cornella H, Ceder Y. microRNAs as cancer therapeutics: a step closer to clinical application. Cancer Lett. 2017;407:113\u201322.","journal-title":"Cancer Lett"},{"issue":"20","key":"926_CR12","first-page":"4786","volume":"119","author":"P Ranganathan","year":"2012","unstructured":"Ranganathan P, Heaphy CE, Costinean S, Stauffer N, Na C, Hamadani M, et al. Regulation of acute graft-versus-host disease by microRNA-155. J Am Soc Hematol. 2012;119(20):4786\u201397.","journal-title":"J Am Soc Hematol"},{"issue":"1","key":"926_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7150\/ijbs.74227","volume":"19","author":"X Han","year":"2023","unstructured":"Han X, Li M, Xu J, Fu J, Wang X, Wang J, et al. miR-1275 targets MDK\/AKT signaling to inhibit breast cancer chemoresistance by lessening the properties of cancer stem cells. Int J Biol Sci. 2023;19(1):89\u2013103.","journal-title":"Int J Biol Sci"},{"issue":"17","key":"926_CR14","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.febslet.2015.06.038","volume":"589","author":"IO Fawzy","year":"2015","unstructured":"Fawzy IO, Hamza MT, Hosny KA, Esmat G, El Tayebi HM, Abdelaziz AI. miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma. FEBS Lett. 2015;589(17):2257\u201365.","journal-title":"FEBS Lett"},{"issue":"9","key":"926_CR15","first-page":"2680","volume":"22","author":"J He","year":"2018","unstructured":"He J, Yu L, Wang C, Zhou XJ. MiR-1275 promotes non-small cell lung cancer cell proliferation and metastasis by regulating LZTS3 expression. Eur Rev Med Pharmacol Sci. 2018;22(9):2680\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"926_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41419-023-05584-8","volume":"14","author":"Q Yang","year":"2023","unstructured":"Yang Q, Kong S, Yu J, Xu Y, Tao M, Ma S, et al. MicroRNA miR-1275 coordinately regulates AEA\/LPA signals via targeting FAAH in lipid metabolism reprogramming of gastric cancer. Cell Death Dis. 2023;14(1):62.","journal-title":"Cell Death Dis"},{"key":"926_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2017.12.049","volume":"646","author":"M-D Liu","year":"2018","unstructured":"Liu M-D, Wu H, Wang S, Pang P, Jin S, Sun C-F, et al. MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7. Gene. 2018;646:1\u20137.","journal-title":"Gene"},{"issue":"6","key":"926_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1530\/ERC-11-0082","volume":"18","author":"DM \u00d6zata","year":"2011","unstructured":"\u00d6zata DM, Caramuta S, Velazquez-Fernandez D, Ak\u00e7akaya P, Xie H, H\u00f6\u00f6g A, et al. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer. 2011;18(6):643.","journal-title":"Endocr Relat Cancer"},{"key":"926_CR19","unstructured":"Saadi MI, Bozorgi H, Ramzi M, Noshadi E, Akbari A, Haghighinejad ZK, et al. Characterization of MiR-92b, 1275 and 551 in patients with acute myeloid leukemia and their association with acute graft versus ho disease after hematopoietic stem cell transplantation."},{"issue":"1","key":"926_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12943-020-01152-2","volume":"19","author":"G Liang","year":"2020","unstructured":"Liang G, Ling Y, Mehrpour M, Saw PE, Liu Z, Tan W, et al. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression. Mol Cancer. 2020;19(1):65.","journal-title":"Mol Cancer"},{"issue":"1","key":"926_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jcmm.14784","volume":"24","author":"C Xie","year":"2020","unstructured":"Xie C, Wu Y, Fei Z, Fang Y, Xiao S, Su HJ, et al. MicroRNA-1275 induces radiosensitization in oesophageal cancer by regulating epithelial-to-mesenchymal transition via Wnt\/\u03b2-catenin pathway. J Cell Mol Med. 2020;24(1):747\u201359.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"926_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12079-016-0351-9","volume":"10","author":"K-Y Sun","year":"2016","unstructured":"Sun K-Y, Peng T, Chen Z, Huang J, Zhou X-HJ. MicroRNA-1275 suppresses cell growth, and retards G1\/S transition in human nasopharyngeal carcinoma by down-regulation of HOXB5. J Cell Commun Signal. 2016;10(4):305\u201314.","journal-title":"J Cell Commun Signal"},{"issue":"16","key":"926_CR23","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.febslet.2011.07.015","volume":"585","author":"A Russo","year":"2011","unstructured":"Russo A, Potenza N. Antiviral effects of human microRNAs and conservation of their target sites. FEBS Lett. 2011;585(16):2551\u20135.","journal-title":"FEBS Lett"},{"issue":"11","key":"926_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bbagrm.2011.10.009","volume":"1809","author":"B Berkhout","year":"2011","unstructured":"Berkhout B, Jeang K-T. MicroRNAs in viral gene regulation. Biochim Biophys Acta. 2011;1809(11):587.","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 6","key":"926_CR25","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/ng1793","volume":"38","author":"BR Cullen","year":"2006","unstructured":"Cullen BR. Viruses and microRNAs. Nat Genet. 2006;38(Suppl 6):S25\u201330.","journal-title":"Nat Genet"},{"key":"926_CR26","unstructured":"Bennett JE, Dolin R, Blaser MJ. Mandell, douglas, and bennett's principles and practice of infectious diseases E-book: Elsevier health sciences; 2019."},{"key":"926_CR27","unstructured":"Organization WH. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact. 2021."},{"issue":"25","key":"926_CR28","doi-asserted-by":"publisher","first-page":"18484","DOI":"10.1074\/jbc.M113.458158","volume":"288","author":"Y Wang","year":"2013","unstructured":"Wang Y, Jiang L, Ji X, Yang B, Zhang Y, Fu X-D. Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a\/miR-16-1 in hepatocytes. J Biol Chem. 2013;288(25):18484\u201393.","journal-title":"J Biol Chem"},{"issue":"4","key":"926_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18(4):295\u2013304.","journal-title":"Transplantation"},{"issue":"4","key":"926_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","volume":"97","author":"PA Rowlings","year":"1997","unstructured":"Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97(4):855\u201364.","journal-title":"Br J Haematol"},{"issue":"12","key":"926_CR31","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/cncr.20668","volume":"101","author":"H Kantarjian","year":"2004","unstructured":"Kantarjian H, Thomas D, O\u2019Brien S, Cortes J, Giles F, Jeha S, et al. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004;101(12):2788\u2013801.","journal-title":"Cancer"},{"key":"926_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13193-021-01358-w","volume":"12","author":"MI Saadi","year":"2021","unstructured":"Saadi MI, Ramzi M, Hosseinzadeh M, Ebrahimi N, Owjfard M, Abdolyousefi EN, et al. Expression Levels of Il-6 and Il-18 in Acute Myeloid Leukemia and Its Relation with Response to Therapy and Acute GvHD After Bone Marrow Transplantation. Indian J Surg Oncol. 2021;12:1\u20137.","journal-title":"Indian J Surg Oncol"},{"issue":"3","key":"926_CR33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12288-018-01066-6","volume":"35","author":"M Iravani Saadi","year":"2019","unstructured":"Iravani Saadi M, Arandi N, Yaghobi R, Azarpira N, Geramizadeh B, Ramzi M. Aberrant expression of the miR-181b\/miR-222 after hematopoietic stem cell transplantation in patients with acute myeloid leukemia. Indian J Hematol Blood Transfus. 2019;35(3):446\u201350.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"926_CR34","first-page":"001","volume":"28","author":"MI Saadi","year":"2018","unstructured":"Saadi MI, Arandi N, Yaghobi R, Azarpira N, Geramizadeh B, Ramzi M. Up-Regulation of the miR-92a and miR-181a in Patients with Acute Myeloid Leukemia and their Inhibition with Locked Nucleic acid (LNA)-antimiRNA; Introducing c-Kit as a New Target Gene. Int J Hematol Oncol. 2018;28(3):001\u20139.","journal-title":"Int J Hematol Oncol."},{"issue":"2","key":"926_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.15171\/jcvtr.2019.23","volume":"11","author":"MI Saadi","year":"2019","unstructured":"Saadi MI, Beigi MAB, Ghavipishe M, Tahamtan M, Geramizadeh B, Zare A, et al. The circulating level of interleukins 6 and 18 in ischemic and idiopathic dilated cardiomyopathy. J Cardiovas Thoracic Res. 2019;11(2):132.","journal-title":"J Cardiovas Thoracic Res"},{"issue":"5","key":"926_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.coph.2008.06.005","volume":"8","author":"M Garofalo","year":"2008","unstructured":"Garofalo M, Condorelli G. Croce CMJCoip. MicroRNAs in diseases and drug response. Curr Opin Pharmacol. 2008;8(5):661\u20137.","journal-title":"Curr Opin Pharmacol"},{"issue":"10","key":"926_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003420","volume":"3","author":"M Lu","year":"2008","unstructured":"Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, et al. An analysis of human microRNA and disease associations. PLoS ONE. 2008;3(10): e3420.","journal-title":"PLoS ONE"},{"issue":"5824","key":"926_CR38","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic\/microRNA-155 for normal immune function. Science. 2007;316(5824):608\u201311.","journal-title":"Science"},{"issue":"5","key":"926_CR39","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.0610731104","volume":"104","author":"RM O'Connell","year":"2007","unstructured":"O\u2019Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A. 2007;104(5):1604\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"926_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/08830180903093796","volume":"28","author":"E Tili","year":"2009","unstructured":"Tili E, Croce CM, Michaille JJ. miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol. 2009;28(5):264\u201384.","journal-title":"Int Rev Immunol"},{"issue":"18","key":"926_CR41","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1073\/pnas.0602266103","volume":"103","author":"S Costinean","year":"2006","unstructured":"Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, et al. Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A. 2006;103(18):7024\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"926_CR42","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"926_CR43","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1073\/pnas.0500613102","volume":"102","author":"PS Eis","year":"2005","unstructured":"Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A. 2005;102(10):3627\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"926_CR44","doi-asserted-by":"publisher","first-page":"11156","DOI":"10.1002\/jcp.27764","volume":"234","author":"H Xie","year":"2019","unstructured":"Xie H, Huang H, Huang W, Xie Z, Yang Y, Wang F. LncRNA miR143HG suppresses bladder cancer development through inactivating Wnt\/\u03b2-catenin pathway by modulating miR-1275\/AXIN2 axis. J Cell Physiol. 2019;234(7):11156\u201364.","journal-title":"J Cell Physiol"},{"issue":"6","key":"926_CR45","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.7150\/thno.41120","volume":"10","author":"N Jiang","year":"2020","unstructured":"Jiang N, Zou C, Zhu Y, Luo Y, Chen L, Lei Y, et al. HIF-1\u0251-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt\/\u03b2-catenin and Notch signaling. Theranostics. 2020;10(6):2553\u201370.","journal-title":"Theranostics"},{"issue":"1","key":"926_CR46","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1186\/s12885-019-5929-1","volume":"19","author":"JW Mei","year":"2019","unstructured":"Mei JW, Yang ZY, Xiang HG, Bao R, Ye YY, Ren T, et al. MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1. BMC Cancer. 2019;19(1):740.","journal-title":"BMC Cancer"},{"issue":"6","key":"926_CR47","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.21037\/tcr.2018.11.32","volume":"7","author":"L Yuan","year":"2018","unstructured":"Yuan L, Ji M-Y, Lu C, Huang P, Dong W-G. MicroRNA-1275 targets PKC\u03b1 to depress proliferation and the invasion of pancreatic cancer cells. Transl Cancer Res. 2018;7(6):1577\u201385.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"926_CR48","first-page":"103","volume":"126","author":"S Chen","year":"2015","unstructured":"Chen S, Smith BA, Iype J, Prestipino A, Pfeifer D, Grundmann S, et al. MicroRNA-155\u2013deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation. J Am Soc Hematol. 2015;126(1):103\u201312.","journal-title":"J Am Soc Hematol"},{"issue":"12","key":"926_CR49","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.4049\/jimmunol.1701465","volume":"200","author":"NC Zitzer","year":"2018","unstructured":"Zitzer NC, Snyder K, Meng X, Taylor PA, Efebera YA. MicroRNA-155 modulates acute graft-versus-host disease by impacting T cell expansion migration, and effector function. J Immunol. 2018;200(12):4170\u20139.","journal-title":"J Immunol"},{"issue":"20","key":"926_CR50","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1182\/blood-2011-10-387522","volume":"119","author":"P Ranganathan","year":"2012","unstructured":"Ranganathan P, Heaphy CE, Costinean S, Stauffer N, Na C, Hamadani M, et al. Regulation of acute graft-versus-host disease by microRNA-155. Blood. 2012;119(20):4786\u201397.","journal-title":"Blood"},{"issue":"3","key":"926_CR51","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/ctr.12314","volume":"28","author":"LN Xie","year":"2014","unstructured":"Xie LN, Zhou F, Liu XM, Fang Y, Yu Z, Song NX, et al. Serum microRNA155 is increased in patients with acute graft-versus-host disease. Clin Transplant. 2014;28(3):314\u201323.","journal-title":"Clin Transplant"},{"key":"926_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fimmu.2016.00056","volume":"7","author":"S Atarod","year":"2016","unstructured":"Atarod S, Ahmed MM, Lendrem C, Pearce KF, Cope W, Norden J, et al. miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence. Front Immunol. 2016;7:56.","journal-title":"Front Immunol"},{"issue":"2","key":"926_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10571-022-01200-z","volume":"43","author":"SH Rastegar-Moghaddam","year":"2023","unstructured":"Rastegar-Moghaddam SH, Ebrahimzadeh-Bideskan A, Shahba S, Malvandi AM, Mohammadipour A. Roles of the miR-155 in neuroinflammation and neurological disorders: a potent biological and therapeutic target. Cell Mol Neurobiol. 2023;43(2):455\u201367.","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"926_CR54","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s10753-021-01566-0","volume":"45","author":"P Purohit","year":"2022","unstructured":"Purohit P, Roy D, Dwivedi S, Nebhinani N, Sharma P. Association of miR-155, miR-187 and inflammatory cytokines IL-6, IL-10 and TNF-\u03b1 in chronic opium abusers. Inflammation. 2022;45(2):554\u201366.","journal-title":"Inflammation"},{"issue":"2","key":"926_CR55","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12291-022-01101-4","volume":"39","author":"SA Abdel-Samed","year":"2022","unstructured":"Abdel-Samed SA, Hozyen WG, Shaaban SM, Hasona NA. Biochemical significance of miR-155 and miR-375 as diagnostic biomarkers and their correlation with the NF-\u03ba\u03b2\/TNF-\u03b1 axis in breast cancer. Indian J Clin Biochem. 2022;39(2):226\u201332.","journal-title":"Indian J Clin Biochem"},{"issue":"5","key":"926_CR56","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/0952-7915(93)90139-J","volume":"5","author":"JL Ferrara","year":"1993","unstructured":"Ferrara JL, Coii J. Cytokine dysregulation as a mechanism of graft versus host disease. Current Opin Immunol. 1993;5(5):794\u20139.","journal-title":"Current Opin Immunol"},{"issue":"5","key":"926_CR57","first-page":"881","volume":"17","author":"N Fujii","year":"2006","unstructured":"Fujii N, Hiraki A, Aoe K, Murakami T, Ikeda K, Masuda K, et al. Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array. Int J Mol Med. 2006;17(5):881\u20135.","journal-title":"Int J Mol Med"},{"issue":"5","key":"926_CR58","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1083-8791(03)00087-9","volume":"9","author":"R Korngold","year":"2003","unstructured":"Korngold R, Marini JC, de Baca ME, Murphy GF. Giles-Komar JJBoB, Transplantation M. Role of tumor necrosis factor-\u03b1 in graft-versus-host disease and graft-versus-leukemia responses. Biol Blood Marrow Transpl. 2003;9(5):292\u2013303.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"926_CR59","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.4049\/jimmunol.179.8.5082","volume":"179","author":"E Tili","year":"2007","unstructured":"Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide\/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007;179(8):5082\u20139.","journal-title":"J Immunol"},{"key":"926_CR60","unstructured":"Saadi MI, Bozorgi H, Ramzi M, Noshadi E, Akbari A, Jamhiri I, et al. International Journal of Hematology and Therapy ISSN: 2381\u20131404. 2020."},{"key":"926_CR61","unstructured":"Bozorgi H, Ramzi M, Noshadi E, Akbari A, Jamhiri I, Haghighinejad H, et al. Characterization of MiR-92b,1275 and 551 in patients with acute myeloid leukemia and their association with acute graft versus host disease after hematopoietic stem cell transplantation. 2020."},{"issue":"12","key":"926_CR62","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/cells8121504","volume":"8","author":"K Sartorius","year":"2019","unstructured":"Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, et al. The regulatory role of MicroRNA in hepatitis-B virus-associated hepatocellular carcinoma (HBV-HCC) pathogenesis. Cells. 2019;8(12):1504.","journal-title":"Cells"},{"issue":"4","key":"926_CR63","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/cbf.3488","volume":"38","author":"L Chen","year":"2020","unstructured":"Chen L, Ming X, Li W, Bi M, Yan B, Wang X, et al. The microRNA-155 mediates hepatitis B virus replication by reinforcing SOCS1 signalling\u2013induced autophagy. Cell Biochem Fun. 2020;38(4):436\u201342.","journal-title":"Cell Biochem Fun"},{"key":"926_CR64","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00018-018-2753-8","volume":"75","author":"W Wang","year":"2018","unstructured":"Wang W, Bian H, Li F, Li X, Zhang D, Sun S, et al. HBeAg induces the expression of macrophage miR-155 to accelerate liver injury via promoting production of inflammatory cytokines. Cell Molecular Life Sci. 2018;75:2627\u201341.","journal-title":"Cell Molecular Life Sci"},{"issue":"10","key":"926_CR65","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/jvh.12390","volume":"22","author":"N Sarkar","year":"2015","unstructured":"Sarkar N, Panigrahi R, Pal A, Biswas A, Singh S, Kar S, et al. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C\/EBP-\u03b2 in hepatocytes. J Viral Hepatitis. 2015;22(10):817\u201327.","journal-title":"J Viral Hepatitis"},{"issue":"3","key":"926_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jinf.2014.10.017","volume":"70","author":"S Akamatsu","year":"2015","unstructured":"Akamatsu S, Hayes CN, Tsuge M, Miki D, Akiyama R, Abe H, et al. Differences in serum microRNA profiles in hepatitis B and C virus infection. J Infect. 2015;70(3):273\u201387.","journal-title":"J Infect"},{"issue":"2","key":"926_CR67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.antiviral.2010.08.008","volume":"88","author":"G-l Zhang","year":"2010","unstructured":"Zhang G-l, Li Y-x, Zheng S-Q, Liu M, Li X, Tang H. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res. 2010;88(2):169\u201375.","journal-title":"Antiviral Res"},{"issue":"9","key":"926_CR68","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1111\/jvh.12240","volume":"21","author":"T Kohno","year":"2014","unstructured":"Kohno T, Tsuge M, Murakami E, Hiraga N, Abe H, Miki D, et al. Human micro RNA hsa-mi R-1231 suppresses hepatitis B virus replication by targeting core m RNA. J Viral Hepatitis. 2014;21(9):e89\u201397.","journal-title":"J Viral Hepatitis"},{"issue":"10","key":"926_CR69","doi-asserted-by":"publisher","first-page":"e01919","DOI":"10.1128\/JVI.01919-16","volume":"91","author":"X Yang","year":"2017","unstructured":"Yang X, Li H, Sun H, Fan H, Hu Y, Liu M, et al. Hepatitis B virus-encoded microRNA controls viral replication. J Virol. 2017;91(10):e01919-e2016.","journal-title":"J Virol"},{"issue":"23","key":"926_CR70","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.1158\/0008-5472.CAN-10-1001","volume":"70","author":"L-M Li","year":"2010","unstructured":"Li L-M, Hu Z-B, Zhou Z-X, Chen X, Liu F-Y, Zhang J-F, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinomaserum miRNA as biomarkers for HBV and HCC. Can Res. 2010;70(23):9798\u2013807.","journal-title":"Can Res"}],"container-title":["VirusDisease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13337-025-00926-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13337-025-00926-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13337-025-00926-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:03:14Z","timestamp":1758891794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13337-025-00926-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1007\/s13337-025-00926-w","relation":{},"ISSN":["2347-3584","2347-3517"],"issn-type":[{"value":"2347-3584","type":"print"},{"value":"2347-3517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All stages were approved by the Ethics Committee of Shiraz University of Medical Sciences (Code: IR.SUMS.MED.REC. 1400.629). In this study, human participation is in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki Declaration and its subsequent amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}